Cabot Corporation (CBT) support and resistance · P/E 16, rev $3.71B
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
This page maps Cabot Corporation (CBT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. Revenue was down 7.0% from 2024-09-30 to 2025-09-30. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CBT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CBT quote page for the session range and the stock page for the full model.
Not investment advice.